ENT Devices Market is Expected to Grow at a Probable CAGR of 6.2% During Forecast 2018-2023

Market Highlights:
The global ENT devices market is expected to grow at an approximate CAGR of 6.2% during forecast period, 2018–2023.
Rising cases of hearing loss is the key factor driving the ENT devices market. As per the 2017 study published in The Hearing Journal, nearly 44 million US adults over the age of 20 are expected to have hearing loss by 2020.
Various other factors such as favorable reimbursement for ENT procedures, high prevalence of chronic sinusitis, geriatric population, technological advancements, growing adoption of minimally invasive ENT procedures, and high demand for cosmetic ENT procedures are also expected to propel the growth of the market.
However, low high cost of CO2 lasers, and high cost of devices can hinder the market growth over the forecast period.
Key Players:
·         Atos Medical A
·         Cochlear Limited
·         Hoya Corporation
·         Johnson & Johnson Services
·         Karl Storz Gmbh & Co. Kg
·         Medtronic PLC
·         Olympus Corporation
·         Rion Co. Ltd
·         Siemens Healthcare
·         Smith & Nephew PLC
·         Sonova Holding AG

Browse Full Report Details and Full TOC Exclusively @ https://www.marketresearchfuture.com/reports/ent-devices-market-7197
Segmentation:
·         The global ENT devices market is segmented based on product, end user, and region.
·         The global market for ENT devices, by product is segmented into diagnostic devices, surgical devices, hearing aids, hearing implants, Co2 lasers, and image-guided surgery systems. The diagnostic devices segment is further classified as endoscopes and hearing screening devices. The endoscopes further segmented as rigid endoscopes and flexible endoscopes. The rigid endoscope segment includes otoscopes and sinuscopes. The flexible endoscope segment includes rhinoscopes, laryngoscopes,  pharyngoscopes, and nasopharyngoscopes. The surgical devices segment is further classified as powered surgical instruments, radiofrequency (RF) handpieces, handheld instruments, balloon sinus dilation devices, ENT supplies, ear tubes, voice prosthesis devices. The handheld instrument segment includes rhinology instruments, otology instruments, laryngeal instruments, head and neck surgery instruments and others. The ENT supplies segment includes packing material, nasal stents & splints.
·         Based on end user, the market is segmented into hospitals, ambulatory settings, ENT clinics, research and academic institutes, home care settings, and others.
Regional Analysis:
The Americas dominated the global market for ENT devices owing to the presence of major market players, increasing cases of hearing loss and developed economies like US and Canada within the region.
In 2017, it was estimated that Europe stood second in the global ENT devices market. This can be attributed to the rising research and development investments and increasing technological advancements.
Asia Pacific was projected to be the fastest growing region in 2017. Increasing healthcare expenditure drives the regional markets of the Asia Pacific region. According to the data suggested by the Australian Institute of Health and Welfare, Australia spent nearly USD 181 billion on health in 2016–2017.
On the other hand, the Middle East and Africa held least share in the global ENT devices market due to the low per capita income, especially within the African region.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more